Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A1 | P13866 | 1/20 | 0.40 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.40 |
| ▸ | GPR139 | Q6DWJ6 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PDE2A | O00408 | 8/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MLYCD | O95822 | 2/20 | 0.35 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6173023 | 0.89 | IGF1R (0.38) | GPR139PDE2APOLBL3MBTL1CYP3A4 | |
| SCHEMBL4849527 | 0.89 | PDE2A (0.37) | GPR139PDE2APOLBL3MBTL1CYP3A4 | |
| SCHEMBL6174371 | 0.88 | IGF1R (0.44) | MAPTPDE2A | |
| SCHEMBL6173852 | 0.87 | IGF1R (0.37) | MAPTMLYCD | |
| SCHEMBL6171821 | 0.87 | PDE2A (0.39) | GPR139PDE2APOLBL3MBTL1CYP3A4 | |
| SCHEMBL6176257 | 0.86 | MAPT (0.41) | SLC5A1SLC5A2GPR139MAPTPDE2A | |
| SCHEMBL6174616 | 0.85 | IGF1R (0.40) | GPR139PDE2APOLBL3MBTL1CYP3A4 | |
| SCHEMBL6174008 | 0.85 | POLB (0.41) | GPR139MAPTPDE2APOLBL3MBTL1 | |
| SCHEMBL6171486 | 0.84 | POLB (0.39) | GPR139PDE2APOLBL3MBTL1CYP3A4 | |
| SCHEMBL6174854 | 0.84 | POLB (0.36) | GPR139PDE2APOLBL3MBTL1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004070050-A2 | CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | WO | disclosed |